Bangkok--17 Oct--Hill & Knowlton
Roche Thailand and Roche Diagnostics (Thailand) have recently held the ‘SOAR: Aim High — Fly Together’ seminar where leading hepatologists in the Asia-Pacific region, namely from Prince of Songkla University and Siriraj Hospital have announced the latest innovation in life-changing hepatitis B management. The new approach offers a combination of medical treatment and viral marker testing that increases the chances of improved long term outcomes toward a clinical cure, thereby bringing new hope to the estimated 3.5 million Thais suffering from Hepatitis B. The treatment is in line with the concept of Personalised Healthcare (PHC), which aims to fit treatment to each patient for the most effective disease management. The seminar was well attended by leading Thai hepatologists at InterContinental Hotel, Bangkok.
Photo shows (from left): Khun Pichetpong Srisuwankul, Managing Director of Roche Diagnostics (Thailand) Ltd.; Associate Professor Tawesak Tanwandee, M.D. Division of Gastroenterology, Department of medicine, Siriraj Hospital, Mahidol University; Associate Professor Teerha Piratvisuth, Director of NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University; and Dr Rolf Ammelburg, General Manager of Roche Thailand Ltd.; at the ‘SOAR: Aim High — Fly Together’ seminar.
Media contact
Kalle Siebring and Sornsopin Puttachartsaewee
Hill & Knowlton Thailand
Tel +66 02 6273501 ext 101
E-mail:
[email protected]
Aurachorn Inkanuwat
Roche Thailand
Tel: +66 2 792 4010
E-mail:
[email protected]